GLENMARK Pharmaceuticals said on Monday its unit entered an outof-court settlement with Glaxo-SmithKline LLC over patent actions on doses of atovaquone and proguanil hydrochloride, the generic version of GSK
Links:
[1] http://admin.indiaenvironmentportal.org.in/news/glenmark-settles-malaria-drug-patent-row-gsk
[2] http://admin.indiaenvironmentportal.org.in/category/newspaper/economic-times-new-delhi
[3] http://admin.indiaenvironmentportal.org.in/category/thesaurus/health
[4] http://admin.indiaenvironmentportal.org.in/category/thesaurus/malaria
[5] http://admin.indiaenvironmentportal.org.in/category/thesaurus/health-care
[6] http://admin.indiaenvironmentportal.org.in/category/thesaurus/drugs
[7] http://admin.indiaenvironmentportal.org.in/category/thesaurus/drug-industry
[8] http://admin.indiaenvironmentportal.org.in/category/thesaurus/patents